Overview
- 13 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2025-12-10.
At a glance
Inspections
13
Form 483s
1
EIRs
2
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 8 Dec 2025 – 10 Dec 2025 | Human Drugs | Clean | |
| 15 Apr 2024 – 1 May 2024 | Human Drugs | Clean | |
| 8 Jan 2024 – 19 Jan 2024 | Human Drugs | Clean | |
| 12 Oct 2021 – 15 Oct 2021 | Human Drugs | Clean | |
| 14 Dec 2020 – 21 Dec 2020 | Human Drugs | Clean | |
| 13 Jan 2020 – 17 Jan 2020 | Human Drugs | Clean | |
| 4 Sep 2018 – 17 Sep 2018 | Human Drugs | Clean | |
| 6 Aug 2018 – 10 Aug 2018 | Human Drugs | Clean | |
| 11 Jun 2018 – 18 Jun 2018 | Human Drugs | Clean | |
| 27 Jun 2017 – 30 Jun 2017 | Human Drugs | Clean | |
| 28 Nov 2016 – 30 Nov 2016 | Human Drugs | Clean | |
| 6 Feb 2013 – 22 Feb 2013 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Iram R Hassan5 insp.
Benton M Ketron3 insp.
Joy P Matthias3 insp.
Melkamu Getie Kebtie2 insp.
Kerun Hardeo1 insp.
Michael F Skelly1 insp.
Lata C Mathew1 insp.
Jogy George1 insp.
Joanne M Schlossin1 insp.
Paul C Mouris1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 600.80(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Regeneron Pharmaceuticals Inc's 1 Form 483
Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat